Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Quanterix
QTRX
$164M
| $12.7M | ﹤0.01% |
217,040
+17,561
| +9% | +$1.02M |
|
|
ECHO
1877
EchoStar
ECHO
$24.4B
| $12.7M | ﹤0.01% |
523,022
+89,118
| +21% | +$2.29M |
|
1878
Griffon
GFF
$3.95B
| $12.6M | ﹤0.01% |
493,247
+10,012
| +2% | +$267K |
|
1879
Repay Holdings
RPAY
$331M
| $12.6M | ﹤0.01% |
525,498
+29,543
| +6% | +$692K |
|
1880
Protagonist Therapeutics
PTGX
$8.79B
| $12.6M | ﹤0.01% |
281,378
+19,791
| +8% | +$653K |
|
1881
Sotera Health
SHC
$5.09B
| $12.6M | ﹤0.01% |
520,493
+24,011
| +5% | +$591K |
|
|
SLCA
1882
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $12.6M | ﹤0.01% |
1,088,329
-194,315
| -15% | -$2.25M |
|
1883
Axsome Therapeutics
AXSM
$11.2B
| $12.6M | ﹤0.01% |
186,095
+3,253
| +2% | +$195K |
|
|
PRO
1884
DELISTED
PROS Holdings
PRO
| $12.5M | ﹤0.01% |
275,179
+2,751
| +1% | +$122K |
|
1885
Amdocs
DOX
$5.92B
| $12.5M | ﹤0.01% |
161,986
+27,657
| +21% | +$2.14M |
|
|
ZUO
1886
DELISTED
Zuora, Inc.
ZUO
| $12.5M | ﹤0.01% |
724,175
+26,087
| +4% | +$417K |
|
1887
Interface
TILE
$1.99B
| $12.5M | ﹤0.01% |
815,794
+18,723
| +2% | +$269K |
|
1888
1st Source
SRCE
$2.16B
| $12.5M | ﹤0.01% |
268,544
+23,150
| +9% | +$1.11M |
|
1889
TriMas Corp
TRS
$1.43B
| $12.5M | ﹤0.01% |
411,189
+16,572
| +4% | +$526K |
|
1890
Bally's
BALY
$682M
| $12.4M | ﹤0.01% |
229,925
+100,662
| +78% | +$5.67M |
|
|
MRC
1891
DELISTED
MRC Global
MRC
| $12.3M | ﹤0.01% |
1,312,927
-44,186
| -3% | -$449K |
|
1892
Donnelley Financial Solutions
DFIN
$1.16B
| $12.3M | ﹤0.01% |
372,722
-33,908
| -8% | -$1.01M |
|
1893
Peabody Energy
BTU
$2.6B
| $12.3M | ﹤0.01% |
1,549,721
+100,856
| +7% | +$597K |
|
|
TPC
1894
Tutor Perini Cor
TPC
$4.41B
| $12.3M | ﹤0.01% |
886,138
-14,667
| -2% | -$234K |
|
1895
Adtran
ADTN
$689M
| $12.3M | ﹤0.01% |
594,188
+3,667
| +0.6% | +$70.9K |
|
|
CSW
1896
CSW Industrials
CSW
$5.2B
| $12.3M | ﹤0.01% |
103,451
+6,382
| +7% | +$814K |
|
1897
Cohu
COHU
$2.26B
| $12.2M | ﹤0.01% |
332,488
+22,139
| +7% | +$878K |
|
1898
MarineMax
HZO
$759M
| $12.2M | ﹤0.01% |
250,953
-12,705
| -5% | -$663K |
|
|
CHCT
1899
Community Healthcare Trust
CHCT
$523M
| $12.2M | ﹤0.01% |
256,733
+8,145
| +3% | +$398K |
|
1900
Customers Bancorp
CUBI
$2.66B
| $12.2M | ﹤0.01% |
311,877
-12,296
| -4% | -$443K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.